Identification of 6-octadecynoic acid from a methanol extract of Marrubium vulgare L. as a peroxisome proliferator-activated receptor γ agonist

Biochemical and Biophysical Research Communications

Volumn 440, Issue 2, 2013, Pages 204-209

  Ohtera, Anna ^a   Miyamae, Yusaku ^a   Nakai, Naomi ^a   Kawachi, Atsushi ^b   Kawada, Kiyokazu ^b   Han, Junkyu ^b   Isoda, Hiroko ^b   Neffati, Mohamed ^c   Akita, Toru ^d   Maejima, Kazuhiro ^d   Masuda, Seiji ^a   Kambe, Taiho ^a   Mori, Naoki ^a   Irie, Kazuhiro ^a   Nagao, Masaya ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Arid and Oases Cropping Laboratory   (Tunisia)

^d NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

6 Octadecynoic acid; Lipid accumulation; Marrubium vulgare L.; Peroxisome proliferator activated receptor (PPAR )

Indexed keywords

6 OCTADECYNOIC ACID; FATTY ACID; LIGAND; LIPID; LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; BIOLOGICAL ACTIVITY; CELL STRAIN HEPG2; DIABETES MELLITUS; DNA BINDING; ENZYME ACTIVITY; ENZYME PURIFICATION; FIBROGENESIS; FIBROSIS; LIPID STORAGE; MARRUBIUM; MARRUBIUM VULGARE; MEDICINAL PLANT; PRIORITY JOURNAL; STELLATE CELL; SYNTHESIS;

15-DEOXY-Δ12,14-PROSTAGLANDIN J(2); 15D-PDJ(2); 6-OCTADECYNOIC ACID; 6-ODA; 9-OCTADECYNOIC ACID; 9-ODA; LIPID ACCUMULATION; MARRUBIUM VULGARE L.; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Γ (PPARΓ); PPARΓ;

3T3-L1 CELLS; ALKYNES; ANIMALS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; HEPATIC STELLATE CELLS; HUMANS; MARRUBIUM; MICE; PLANT EXTRACTS; PPAR GAMMA;

MARRUBIUM VULGARE;

EID: 84885849418     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.003     Document Type: Article

References (26)

1. Sahpaz S., Garbacki N., Tits M., Bailleul F. Isolation and pharmacological activity of phenylpropanoid esters from Marrubium vulgare. J. Ethnopharmacol. 2002, 79:389-392.
2. Herrera-Arellano A., Aguilar-Santamaria L., Garcia-Hernandez B., Nicasio-Torres P., Tortoriello J. Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics. Phytomedicine 2004, 11:561-566.
3. She H., Xiong S., Hazra S., Tsukamoto H. Adipogenic transcriptional regulation of hepatic stellate cells. J. Biol. Chem. 2005, 280:4959-4967.
4. Martin H. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat. Res. 2009, 669:1-7.
5. Allred C.D., Talbert D.R., Southard R.C., Wang X., Kilgore M.W. PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J. Nutr. 2008, 138:250-256.
6. Li X.C., Jacob M.R., Khan S.I., Ashfaq M.K., Babu K.S., Agarwal A.K., Elsohly H.N., Manly S.P., Clark A.M. Potent in vitro antifungal activities of naturally occurring acetylenic acids. Antimicrob. Agents Chemother. 2008, 52:2442-2448.
7. Sadowski I., Ptashne M. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 1989, 17:7539.
8. Pugh C.W., O'Rourke J.F., Nagao M., Gleadle J.M., Ratcliffe P.J. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J. Biol. Chem. 1997, 272:11205-11214.
9. Seiler-Tuyns A., Eldridge J.D., Paterson B.M. Expression and regulation of chicken actin genes introduced into mouse myogenic and nonmyogenic cells. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:2980-2984.
10. Eustice D.C., Feldman P.A., Colberg-Poley A.M., Buckery R.M., Neubauer R.H. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques 1991, 11:739-740. 742-733.
11. Sakaue H., Ogawa W., Matsumoto M., Kuroda S., Takata M., Sugimoto T., Spiegelman B.M., Kasuga M. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J. Biol. Chem. 1998, 273:28945-28952.
12. Gao Y., Yang M.F., Su Y.P., Jiang H.M., You X.J., Yang Y.J., Zhang H.L. Ginsenoside Re reduces insulin resistance through activation of PPAR-gamma pathway and inhibition of TNF-alpha production. J. Ethnopharmacol. 2013, 147:509-516.
13. Shak S., Reich N.O., Goldstein I.M., Ortiz de Montellano P.R. Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Suicidal inactivation by acetylenic fatty acids. J. Biol. Chem. 1985, 260:13023-13028.
14. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 2008, 77:289-312.
15. Waku T., Shiraki T., Oyama T., Maebara K., Nakamori R., Morikawa K. The nuclear receptor PPARgamma individually responds to serotonin- and fatty acid-metabolites. EMBO J. 2010, 29:3395-3407.
16. Penumetcha M., Santanam N. Nutraceuticals as Ligands of PPARgamma. PPAR Res. 2012, 2012:858352.
17. Leesnitzer L.M., Parks D.J., Bledsoe R.K., Cobb J.E., Collins J.L., Consler T.G., Davis R.G., Hull-Ryde E.A., Lenhard J.M., Patel L., Plunket K.D., Shenk J.L., Stimmel J.B., Therapontos C., Willson T.M., Blanchard S.G. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 2002, 41:6640-6650.
18. Kang K., Liu W., Albright K.J., Park Y., Pariza M.W. Trans-10, cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR gamma expression. Biochem. Biophys. Res. Commun. 2003, 303:795-799.
19. Granlund L., Juvet L.K., Pedersen J.I., Nebb H.I. Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J. Lipid Res. 2003, 44:1441-1452.
20. Yang J.Y., Della-Fera M.A., Rayalam S., Park H.J., Ambati S., Hausman D.B., Hartzell D.L., Baile C.A. Regulation of adipogenesis by medium-chain fatty acids in the absence of hormonal cocktail. J. Nutr. Biochem. 2009, 20:537-543.
21. Steger A., van Loon J. Fat of the seed of Picramnia sow. Recl. Trav. Chim. Pay. B 1933, 52:593-600.
22. Lumb P.B., Smith J.C. Higher aliphatic compounds X. Synthesis of tariric and petroselinic acids. J. Chem. Soc. 1952, 5032-5035.
23. Hirasawa A., Hara T., Katsuma S., Adachi T., Tsujimoto G. Free fatty acid receptors and drug discovery. Biol. Pharm. Bull. 2008, 31:1847-1851.
24. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., Fujino M. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003, 422:173-176.
25. Edfalk S., Steneberg P., Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 2008, 57:2280-2287.
26. Burant C.F., Viswanathan P., Marcinak J., Cao C., Vakilynejad M., Xie B., Leifke E. TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2012, 379:1403-1411.